Orange Book product · Generic (ANDA)
MELOXICAM
MELOXICAM
At a glance
Jun 01, 2020
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 01, 2020
6 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
MELOXICAM
Strength
5MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 209487
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of MELOXICAM
- 2025XIFYRMBrand (NDA)
NDA 218395 · AZURITY
- 2025QAMZOVABrand (NDA)
NDA 217593 · NANJING DELOVA
- 2020ANJESOBrand (NDA)
NDA 210583 · BAUDAX
- 2018QMIIZ ODTBrand (NDA)
NDA 211210 · TERSERA
- 2015VIVLODEXBrand (NDA)
NDA 207233 · ICEUTICA OPERATIONS
- 2004MELOXICAMBrand (NDA)
NDA 021530 · AVONDALE PHARMS
- 2000MOBICBrand (NDA)
NDA 020938 · BOEHRINGER INGELHEIM
- 2023MELOXICAMGeneric (ANDA)
ANDA 217579 · ASCENT PHARMS INC
- 2021MELOXICAMGeneric (ANDA)
ANDA 211398 · NOVITIUM PHARMA
- 2009MELOXICAMGeneric (ANDA)
ANDA 077928 · NOVITIUM PHARMA
- 2006MELOXICAMGeneric (ANDA)
ANDA 077927 · UNICHEM
- 2006MELOXICAMGeneric (ANDA)
ANDA 078039 · CR DOUBLE CRANE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
